Newtopia Inc.

Equities

NEWU

CA6532261006

Healthcare Facilities & Services

Market Closed - Toronto S.E. 09:35:56 2024-04-26 am EDT 5-day change 1st Jan Change
0.055 CAD 0.00% Intraday chart for Newtopia Inc. -21.43% -35.29%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Newtopia Up Over 27% After Reporting $746,500 Offering MT
Newtopia Inc. announced that it has received CAD 0.7465 million in funding CI
Newtopia Launches "Glp-1 Sustain" Program to Affordably Preserve and Extend Valuable Health Benefits of Novel Weight Loss Drugs CI
Transcript : Newtopia Inc., Q3 2023 Earnings Call, Nov 16, 2023
Newtopia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Newtopia Brief: Improves Gross Margin (non IFRS) by 1,100 basis points year-over-year MT
Newtopia Brief: Says Achieved EBITDA "Positive" for first full quarter in Company history' Decreases operating expenses by 52% year-over-year MT
Newtopia Brief: Q3 Revenue of $2.43 million, as compared to $2.65 million MT
Newtopia Inc. announced that it has received CAD 0.805 million in funding CI
Newtopia Completed Prior Announced Debenture Extension MT
Newtopia to Amend Convertible Debentures, Proposes Non-Brokered Offering of Subordinated Non-Convertible Debentures MT
Newtopia Inc. announced that it expects to receive CAD 2.545 million in funding CI
Newtopia Higher After Announcing Exercise of Warrants MT
Transcript : Newtopia Inc., Q2 2023 Earnings Call, Aug 09, 2023
Newtopia Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Newtopia Inc. Provides Earnings Guidance for the Year 2023 CI
Newtopia Inc. announced that it has received CAD 1.5 million in funding CI
Newtopia Brief: Says Expects to use the proceeds of the Offering for corporate and general working capital purposes MT
Newtopia Brief: Announcing a proposed non-brokered offering of subordinated and postponed 13% secured non-convertible debenture units pursuant to which Newtopia proposes to raise gross proceeds of up to $500,000 MT
Newtopia Inc. announced that it expects to receive CAD 0.5 million in funding CI
Newtopia Inc. Renews Multi-Year Partnership with Fortune-500 Healthcare Juggernaut to Prevent, Slow and Reverse Chronic Disease Through Sustainable Habit Change CI
Newtopia Brief: As a result of Share Purchase, McCauley Owns and Controls Near 13,994,500 Shares and 1 Million Common Share Purchase Warrants, Representing 10% of Shares On a Partially Diluted Basis MT
Newtopia Brief: Hugh G. McCauley Says Acquired 100,000 Common Shares For a Purchase Price of $0.075 per Share MT
Newtopia Inc. announced that it has received CAD 0.0075 million in funding CI
Newtopia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chart Newtopia Inc.
More charts
Newtopia Inc. is a Canada-based technology-enabled habit change company that delivers disease prevention solutions by leveraging genetic testing, social and behavioral science to help individuals prevent chronic disease and reduce costs for health insurers. As a provider of whole-person care, it prevents, reverses and slows the progression of chronic disease while enriching mental health, resilience and overall human performance. The Company’s programs leverage genetic, social, and behavioral insights to create individualized prevention programs with a focus on type two diabetes, heart disease, stroke, metabolic disease, mental health challenges, hypertension, weight management and musculoskeletal disorders. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, the Company delivers sustainable clinical and financial outcomes. Its personalized habit change platform focuses on physical and mental health risk reduction.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. NEWU Stock
  4. News Newtopia Inc.
  5. Newtopia Brief: Says Expects to use the proceeds of the Offering for corporate and general working capital purposes